Joint Formulary & PAD

Betamethasone - Inflammatory skin conditions

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Cream
  • Ointment
Associated Icons :
SPC
Restrictions / Comments :
Important
Preferred

Betamethasone dipropionate 0.05% (Diprosone) - Potent

 

Status 2

Green
Formulations :
  • Cream
  • Ointment
Associated Icons :
SPC
Restrictions / Comments :
Important

Betamethasone valerate 0.025% cream (Betnovate-RD) moderate potency

Betamethasone valerate 0.025% ointment (Betnovate-RD) moderate potency

 

Status 3

Green
Formulations :
  • Cream
  • Ointment
Associated Icons :
SPC
Restrictions / Comments :
Important

Betamethasone valerate 0.1% cream (Betnovate) - Potent

Betamethasone valerate 0.1% ointment (Betnovate) - Potent

 

Status 4

Green
Formulations :
  • Foam
  • Lotion
  • Scalp application
Associated Icons :
SPC
Restrictions / Comments :
Important

Betamethasone valerate 0.1% scalp application (Betnovate / Betacap) - Potent

Betamethasone 0.1% foam (Bettamousse) - Potent

 

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Betamethasone
Indication :
Inflammatory skin conditions
Group Name :
Keywords :
topical corticosteroids, eczema, dermatoses, dermatitis, psoriasis,
Brand Names Include :
Diprosone, Betnovate, Betnovate-RD, Betacap, Bettamousse
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
4

Committee Recommendations (0)

  • No records returned.